Abbott Laboratories
Market Cap
$189.82B
P/E Ratio
29.37
EPS
$3.72
Dividend Yield
2.19%
52-Week Range
$105.27 — $139.06
Volume
2.80M
Avg Volume
9.70M
Beta
0.74
P/E (TTM)
29.37
Forward P/E
19.24
PEG Ratio
-0.55
P/S (TTM)
4.30
P/B (TTM)
3.68
P/FCF
0.00
EV/EBITDA
0.00x
EV/Sales
—
ROE (TTM)
0.13%
ROA (TTM)
0.08%
ROIC
0.00%
Gross Margin
0.56%
Operating Margin
0.18%
Net Margin
0.15%
Debt/Equity
0.29
Current Ratio
1.58
EPS Growth (YoY)
-0.81%
Revenue Growth (YoY)
+0.04%
EPS Growth (3Y)
+0.22%
EPS Growth (5Y)
+0.24%
Sales Growth (3Y)
+0.01%
Sales Growth (5Y)
+0.06%
EPS Est (This Year)
$5.68
EPS Est (Next Year)
$6.25
Dividend Yield
—
Annual Dividend
$0.63
Payout Ratio
0.58%
Frequency
—
Ex-Dividend Date
2026-01-15
Cash/Share
$5.12
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $134.64(23.3% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.74B
Float
1.73B
Free Float %
99.25%
RSI (14)
49.89
SMA 20
$113.12
SMA 50
$116.15
SMA 200
$126.47
ATR (14)
2.14
Volatility (Week)
0.02%
Volatility (Month)
0.01%
Pattern
—
1 Day
+2.81%
1 Week
-1.30%
1 Month
+3.26%
3 Months
-10.18%
6 Months
-15.27%
1 Year
—
YTD
-9.30%
All-Time High
$141.23
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NYSE
IPO Date
1980-03-17
Employees
114000
CEO
Robert Ford
Index Membership
S&P 500
Website
https://www.abbott.com
Abbott Laboratories (ABT) is a healthcare company in the medical - devices industry listed on the NYSE. With a market capitalization of $189.82B, a P/E ratio of 29.37, and a dividend yield of 2.19%, ABT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABT against other stocks using dozens of fundamental and technical filters.
Abbott Laboratories (ABT) has a trailing twelve-month (TTM) P/E ratio of 29.37. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Abbott Laboratories (ABT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Abbott Laboratories (ABT) has a market capitalization of $189.82 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Abbott Laboratories (ABT) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $134.64 implies 23.3% upside from the current price.
Abbott Laboratories (ABT) has returned -9.30% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.